Private area
Contact Us
Total Visits
| Views | |
|---|---|
| Subcutaneous ... | 123 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Subcutaneous ... | 2 | 6 | 8 | 5 | 8 | 21 | 0 |
File Visits
| Views | |
|---|---|
| subcutaneous_versus_intravenous_amivantamab_both_combination_lazertinib_refractory_epidermal_growth_factor_receptor_mutated_non_small_cell_lung_cancer_primary_results_phase_iii_paloma_3_study_2024.pdf | 99 |
Top country views
| Views | |
|---|---|
| United States | 38 |
| Singapore | 34 |
| Spain | 10 |
| China | 8 |
| Brazil | 6 |
| Hong Kong | 6 |
| Canada | 4 |
| Australia | 3 |
| Germany | 3 |
| United Kingdom | 2 |
Top cities views
| Views | |
|---|---|
| Singapore | 23 |
| Ashburn | 10 |
| Beijing | 8 |
| Barcelona | 4 |
| Hong Kong | 4 |
| Frankfurt am Main | 3 |
| Huntsville | 3 |
| Madrid | 3 |
| Santa Clara | 2 |
| Toronto | 2 |
